Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford contributes around £5.8 billion to the UK economy, and supports more than 50,000 full time jobs. Globally, the impact is £7.1 billion, according to a study carried out by BiGGAR Economics

Oxford University economic impact logo

Similar stories

UK National Health Service begins rollout of Oxford coronavirus vaccine

General OCGHR

The first patients are being vaccinated as part of the UK’s rollout of the Oxford / AstraZeneca coronavirus vaccine, ChAdOx1 nCoV-19, at the Oxford University NHS Hospitals Trust. The Oxford AstraZeneca vaccinations will be delivered at a small number of hospitals for the first few days for surveillance purposes, as is standard practice, before the bulk of supplies are sent to hundreds of GP-led services later in the week.

Oxford Global Research

General KWTRP MORU OCGHR OUCRU

Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. To showcase our global research, the University launched a Global Research Map, highlighting areas of research we are conducting overseas.

Five years at the top: Oxford retains first place in World University Rankings

Awards & Appointments General

Oxford University’s enduring global reputation, cutting edge research and unique teaching environment have helped retain first place in the Times Higher Education World University Rankings for a fifth consecutive year. THE rankings use 13 separate performance indicators to cover universities’ core missions across teaching, research, knowledge transfer and international outlook. The award follows a year when the University of Oxford has been at the centre of international attention for its work on finding a vaccine for COVID-19 as well as taking a leading role in trialling therapeutic drugs and antibody testing.

Why protesting racism during a pandemic is important – an epidemiologist explains

General OCGHR

The Conversation article, by Lakshmi Manoharan, Medical Epidemiologist. Widespread protests have broken out across the US in response to the killings of black Americans at the hands of police. Demonstrations have also erupted in the UK and other countries in solidarity with the Black Lives Matter movement and in protest at these countries’ own domestic cases of institutional racism. These protests are happening in the middle of a pandemic, which raises issues regarding the spread of the virus, and also highlights deep inequalities due to structural racism and its effects on people’s health. Although health authorities rightly discourage congregations of people, these protests may be the only way for the systemically disenfranchised to have their voices heard.

Major medical journals retract Covid-19 studies

General MORU

On 4 June 2020, after a week of increasing scientific concern and scrutiny, first The Lancet, then the New England Journal of Medicine, retracted studies that were based on inaccessible data. The studies have been extremely damaging to chloroquine and hydroxychloroquine COVID-19 clinical trials around the globe. MORU researchers played a key role in bringing this scandal to light, whose consequences continue to play out.

Clinical trials on hydroxychloroquine/ chloroquine in COVID-19. Statement in response to damaging recent events

General MORU Publication

On 4 June 2020, after a week of increasing scientific concern and scrutiny, first The Lancet, then a little over an hour later the New England Journal of Medicine, retracted studies that were based on inaccessible data, provided by the Surgisphere corporation. The studies have been extremely damaging to chloroquine and hydroxychloroquine COVID-19 clinical trials around the globe. Here is MORU’s statement in response to these events.